title: A novel synthetic peptide for the specific treatment of lupus: clinical effects and mechanism of action.
authors.affiliation: Department of Immunology, Weizmann Institute of Science, Rehovot, Israel. edna.mozes@weizmann.ac.il
authors.forename: Edna
authors.initials: E
authors.lastname: Mozes
authors.forename: Uri
authors.initials: U
authors.lastname: Sela
authors.forename: Amir
authors.initials: A
authors.lastname: Sharabi
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001323:Autoantibodies / Q000276:immunology; D022801:Complementarity Determining Regions / Q000494:pharmacology*; D015536:Down-Regulation / Q000187:drug effects; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D010446:Peptide Fragments / Q000494:pharmacology*; D011948:Receptors, Antigen, T-Cell / Q000037:antagonists & inhibitors / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D001323:Autoantibodies; D022801:Complementarity Determining Regions; C481963:FOXJ1 protein, mouse; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors; C474033:FoxO3 protein, mouse; D010446:Peptide Fragments; D011948:Receptors, Antigen, T-Cell